PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
+4.58%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$663M
AUM Growth
+$34.3M
(+5.5%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
47.41%
Holding
224
New
41
Increased
20
Reduced
31
Closed
32
Top Buys
| 1 |
United Therapeutics
UTHR
|
$13.5M |
| 2 |
Cytokinetics
CYTK
|
$12.6M |
| 3 |
Illumina
ILMN
|
$10.5M |
| 4 |
ICU Medical
ICUI
|
$9.41M |
| 5 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
$7.52M |
Top Sells
| 1 |
Biogen
BIIB
|
$25.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 3 |
Pulmonx
LUNG
|
$9.13M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$9.01M |
| 5 |
Evolent Health
EVH
|
$7.06M |
Sector Composition
| 1 | Healthcare | 90.69% |
| 2 | Industrials | 0.83% |
| 3 | Materials | 0.39% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioCryst Pharmaceuticals
BCRX
$1.72B
| $3.49M | 0.2% |
276,629
-87,623
| -24% | -$1.1M |
|
52
ResMed
RMD
$39.9B
| $3.28M | 0.19% |
+15,000
| New | +$3.28M |
|
53
Liquidia Corp
LQDA
$2.45B
| $2.93M | 0.17% |
+537,870
| New | +$2.93M |
|
54
Merus
MRUS
$4.92B
| $2.72M | 0.16% |
+135,632
| New | +$2.72M |
|
|
AMRS
55
DELISTED
Amyris Inc.
AMRS
| $2.56M | 0.15% |
875,000
-175,399
| -17% | -$512K |
|
56
ATAI Life Sciences
ATAI
$930M
| $2.39M | 0.14% |
721,824
| – | – |
|
57
SOPHiA GENETICS
SOPH
$231M
| $2.36M | 0.14% |
896,240
+36,310
| +4% | +$95.5K |
|
|
APEN
58
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.35M | 0.14% |
427,057
| – | – |
|
59
Annexon
ANNX
$226M
| $2.32M | 0.13% |
+374,630
| New | +$2.32M |
|
60
Esperion Therapeutics
ESPR
$492M
| $2.23M | 0.13% |
332,123
+120,000
| +57% | +$804K |
|
61
Pfizer
PFE
$140B
| $2.19M | 0.13% |
+50,000
| New | +$2.19M |
|
62
Amylyx Pharmaceuticals
AMLX
$868M
| $1.93M | 0.11% |
68,652
+58,102
| +551% | +$1.64M |
|
63
Boston Scientific
BSX
$160B
| $1.88M | 0.11% |
+48,635
| New | +$1.88M |
|
64
Revolution Medicines
RVMD
$7.24B
| $1.87M | 0.11% |
+95,000
| New | +$1.87M |
|
|
ICAD
65
DELISTED
iCAD Inc
ICAD
| $1.85M | 0.11% |
880,558
+207,569
| +31% | +$436K |
|
66
GH Research
GHRS
$856M
| $1.84M | 0.11% |
158,327
-50,200
| -24% | -$583K |
|
|
SNCE
67
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $1.78M | 0.1% |
55,320
| – | – |
|
|
NGM
68
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.78M | 0.1% |
+135,696
| New | +$1.78M |
|
|
AKYA
69
DELISTED
Akoya BioSciences
AKYA
| $1.73M | 0.1% |
+147,500
| New | +$1.73M |
|
|
RXDX
70
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.72M | 0.1% |
+29,188
| New | +$1.72M |
|
71
Viridian Therapeutics
VRDN
$1.51B
| $1.54M | 0.09% |
75,003
-30,457
| -29% | -$625K |
|
|
NYXH
72
Nyxoah
NYXH
$218M
| $1.42M | 0.08% |
221,949
| – | – |
|
|
MRTX
73
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.4M | 0.08% |
+20,000
| New | +$1.4M |
|
|
RETA
74
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.4M | 0.08% |
+55,596
| New | +$1.4M |
|
75
Iovance Biotherapeutics
IOVA
$774M
| $1.39M | 0.08% |
+144,528
| New | +$1.39M |
|